Results 171 to 180 of about 994,937 (217)

Temporal changes in device-derived daily activity related to ventricular arrhythmias from the CERTITUDE registry. [PDF]

Heart Rhythm O2
Kutyifa V, Christof M, Mullane S, Harrell C, Singh J, Chinitz L, Varma N, Piccini JP, Turakhia MP, Rosero SZ.   +9 more
europepmc   +1 more source

Patient and Clinician Perspectives on Alert-Based Remote Monitoring-First Care for Cardiovascular Implantable Electronic Devices: Semistructured Interview Study Within the Veterans Health Administration. [PDF]

JMIR Cardio
Kratka A, Rotering TL, Munson S, Raitt MH, Whooley MA, Dhruva S.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Implantable Cardioverter-Defibrillators

American Journal of Therapeutics, 2010
The automatic implantable cardioverter-defibrillator (AICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation. The American College of Cardiology/American Heart Association class I, IIa, and III indications for an AICD are discussed.
Miguel Valderrábano, Jose L. Baez-Escudero   +1 more
openaire   +6 more sources

Implantable cardioverter-defibrillators

Journal of Cardiothoracic and Vascular Anesthesia, 1999
Abstract In the quest to save lives, a greater number of ICDs are implanted each year. These ICDs with pacing capabilities offer a successful therapeutic intervention to a devastating problem. Patients who have these devices will appear in operating rooms around the country. Manage these patients like all other patients who have heart disease, before
Sergio L. Pinski, Gerard J. Fahy
openaire   +6 more sources

Implantable Cardioverter Defibrillator Implantation with or Without Defibrillation Testing

Cardiac Electrophysiology Clinics, 2018
Defibrillation testing (DFT) during implantable cardioverter-defibrillator (ICD) implantation is still considered standard of care in some, but in increasingly fewer centers. The goal is to ensure that the device system functions as intended by testing in the controlled laboratory setting.
Raymond Yee, Imane El Hajjaji, Jaimie Manlucu, Stephen A. Duffett   +3 more
openaire   +2 more sources

implantable atrial defibrillators

Cardiac Electrophysiology Review, 1998
link_to_subscribed_fulltext
Tse, HF, Lau, CP
openaire   +5 more sources

The implantable cardioverter defibrillator

The Lancet, 2001
Implantable cardioverter defibrillators (ICDs) have evolved from the treatment of last resort to the gold standard therapy for patients at high risk for ventricular tachyarrhythmias. High-risk patients include those who have survived life-threatening arrhythmias, and individuals with cardiac diseases who are at risk for such arrhythmias, but are ...
Paul A. Friedman, Michael Glikson
openaire   +3 more sources